ArticleLife (Basel, Switzerland)2026

Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study.

Ping-Huang Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.